A histopathological and stereological study of the effects of acetylsalicylic acid on doxorubicin-induced hepatotoxicity in mice

References

• Aydinli B, Kantarci M, Polat KY, Unal B, Atamanalp SS, Durur I, Unal D, Akgun M. 2006. Stereological evaluation of treatment response in patients with nonresectable hepatic alveolar echinococcosis using computed tomography via the Cavalieri method. Liver Int. 26:1234–1240.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Stevens A. 1996. Theory and practice of histological techniques. 4th ed. Churchill Livingstone: New York; p. 1112–1116.
   Google Scholar
• Farrugia G, Bannister WH, Vassallo N, Balzan R. 2013. Aspirin-induced apoptosis of yeast cells is associated with mitochondrial superoxide radical accumulation and NAD(P)H oxidation. FEMS Yeast Res. 13:755–768.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Zanzotto FM, Scarpato N, Riondino S, Nanni U, Roselli M, Guadagni F. 2017. Risk assessment for venous thromboembolism in chemotherapy-treated ambulatory cancer patients: a machine learning approach. Med Decis Making. 37:234–242.
   PubMed Web of Science ®Google Scholar
• Ganey PE, Kauffman FC, Thurman RG. 1988. Oxygendependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver. Mol Pharmacol. 34:695–701.
   PubMed Web of Science ®Google Scholar
• Gokcimen A, Cim A, Tola HT, Bayram T, Koçak A, Özgüner F, Ayata A. 2007. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity. Hum Exp Toxicol. 26:519–525.
   PubMed Web of Science ®Google Scholar
• Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman SD, Schröder H. 2003. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun. 308:956–960.
   PubMed Web of Science ®Google Scholar
• Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 147:229–263.
   PubMed Web of Science ®Google Scholar
• Gundersen HJ, Jensen EB, Kieu K, Nielsen J. 1999. The efficiency of systematic sampling in stereology–reconsidered. J Microsc. 193:199–211.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. 1984. Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex. Biochem Pharmacol. 33:1725–1728.
   PubMed Web of Science ®Google Scholar
• Herman EH, Zhang J, Hasinoff BB, Clark JR, Ferrans VJ. 1997. Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex. J Mol Cell Cardiol. 29: 2415–2430. ChriaanLeeuwenburgh.
   PubMed Web of Science ®Google Scholar
• Jang YM, Kendaiah S, Drew B, Philips T, Selman C, David J. 2004. Doxorubicin treatment in vivo activities caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 577:483–490.
   PubMed Web of Science ®Google Scholar
• Jordon MA. 2002. Anti-cancer agents. Cur Med Chem. 2:1–17.
   Google Scholar
• Kalender Y, Yel M, Kalender S. 2005. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effect of vitamin E and catechin. Toxicology. 209:39–45.
   PubMed Web of Science ®Google Scholar
• Kapetanovic IM, Bauerb KS, Tessier DM, Lindeblad MO, Zakharov DA, Lubet R, Lyubimov A. 2009. Comparison of pharmacokinetic and pharmacodynamic proles of aspirin following oral gavage and diet dosing in rats. Chem Biol Interac. 179:233–239.
   PubMed Web of Science ®Google Scholar
• Karaduman D, Eren B, Keles ON. 2010. The protective effect of beta-1,3-D-glucan on taxol-induced hepatotoxicity: a histopathological and stereological study. Drug Chem Toxicol. 33:8–16.
   PubMed Web of Science ®Google Scholar
• Karim S, Bhandarı U, Kumar H, Salam A, Sıddıquı MAA, Pıllaı KK. 2001. Doxorubicin induced cardiotoxicity and its modulation by drug. Ind J Pharmacol. 33:203–207.
   Google Scholar
• Liu Y, Thurman RG. 1992. Potentiation of adriamycin toxicity by ethanol in perfused rat liver. J Pharmacol Exp Ther. 263:651–656.
   PubMed Web of Science ®Google Scholar
• Llesuy SF, Arnaiz SL. 1990. Hepatotoxicity of mitoxantrone and doxorubicin. Toxicology. 63:187–198.
   PubMed Web of Science ®Google Scholar
• Maskos Z, Rush JD, Koppenol WH. 1990. The hydroxylation of the salicylate anion by a Fenton reaction and γ-radiolysis: a consideration of the respective mechanisms. Free Rad Biol Med. 8:153–162.
   PubMed Web of Science ®Google Scholar
• Okutan O, Ayten Ö. 2014. Venöz tromboembolizm ve kanser. Tuberk Toraks. 62:301–315.
   PubMedGoogle Scholar
• Pedrycz A, Wieczorski M, Czerny K. 2004. The influence of a single dose of adriamycin on the pregnant rat female liver-histological and histochemical evaluation. Ann Univ Mariae Curie Sklodowska. 59:319–323.
   PubMedGoogle Scholar
• Reszka KJ, Britigan LH, Britigan BE. 2005. Oxidation of anthracyclines by peroxidase metabolites of salicylic acid. J Pharmacol Exp Ther. 31:283–290.
   Google Scholar
• Roberts LJ, Morrow JD. 2001. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman’s the pharmarcological basis of therapeutics. McGraw-Hill: Columbus, OH; p. 687–731.
   Google Scholar
• Shi X, Ding M, Dong Z, Chen F, Ye J, Wang S, Leonard SS, Castranova V, Vallyathan V. 1999. Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kB activation, and TNF-α production. Mol Cell Biochem. 199:93–102.
   PubMed Web of Science ®Google Scholar
• Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. 2011. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogen Genom. 21:440–446.
   PubMed Web of Science ®Google Scholar
• Waldron M, Siebenaller C, Earl M, Jia X, Carraway HE, Advani AS, Nazha A, Gerda AT, Hamilton MK, Sobecks R, Kalaycio M, Tripp B, Hobbs BP, Sekeres MA, Mukherjee S. 2018. Impact of venous thromboembolism during high ıntensity chemotherapy for acute leukemia patients on duration of hospital stay. Blood. 132:4806.
   Web of Science ®Google Scholar
• Weiss RB. 1992. The anthracyclines: will we ever find a better doxorubicin? Sem Oncol. 19:670–686.
   PubMed Web of Science ®Google Scholar
• Ying Z, Giachini FRC, Tostes RC, Webb RC. 2009. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovasc Res. 83:155–162.
   PubMed Web of Science ®Google Scholar